- Home
- LRMR vs BANX Comparison
LRMR vs BANX Comparison
Compare LRMR & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- BANX
- Stock Information
- Founded
- LRMR N/A
- BANX 2013
- Country
- LRMR United States
- BANX United States
- Employees
- LRMR N/A
- BANX N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- BANX Trusts Except Educational Religious and Charitable
- Sector
- LRMR Health Care
- BANX Finance
- Exchange
- LRMR Nasdaq
- BANX Nasdaq
- Market Cap
- LRMR 183.8M
- BANX 143.2M
- IPO Year
- LRMR N/A
- BANX N/A
- Fundamental
- Price
- LRMR $2.24
- BANX $20.24
- Analyst Decision
- LRMR Strong Buy
- BANX
- Analyst Count
- LRMR 9
- BANX 0
- Target Price
- LRMR $19.00
- BANX N/A
- AVG Volume (30 Days)
- LRMR 1.4M
- BANX 16.3K
- Earning Date
- LRMR 04-30-2025
- BANX 06-13-2025
- Dividend Yield
- LRMR N/A
- BANX 10.50%
- EPS Growth
- LRMR N/A
- BANX N/A
- EPS
- LRMR N/A
- BANX 2.35
- Revenue
- LRMR N/A
- BANX $29,467,794.00
- Revenue This Year
- LRMR N/A
- BANX N/A
- Revenue Next Year
- LRMR N/A
- BANX N/A
- P/E Ratio
- LRMR N/A
- BANX $8.50
- Revenue Growth
- LRMR N/A
- BANX 2.73
- 52 Week Low
- LRMR $1.61
- BANX $17.91
- 52 Week High
- LRMR $11.20
- BANX $21.67
- Technical
- Relative Strength Index (RSI)
- LRMR 47.46
- BANX 51.92
- Support Level
- LRMR $2.03
- BANX $19.93
- Resistance Level
- LRMR $3.07
- BANX $20.28
- Average True Range (ATR)
- LRMR 0.30
- BANX 0.43
- MACD
- LRMR 0.01
- BANX 0.06
- Stochastic Oscillator
- LRMR 31.12
- BANX 58.56
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds, and others.